Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Neumora Therapeutics | NMRA | Sep 20, 2024 | 12.92 | +1.49 |
Neuraxis | NRXS | Sep 20, 2024 | 2.60 | -11.26 |
Neurobo Pharmaceuticals | NRBO | Sep 20, 2024 | 3.19 | -2.15 |
Neurocrine Biosciences | NBIX | Sep 20, 2024 | 118.35 | -1.75 |
Neurogene | NGNE | Sep 20, 2024 | 40.75 | -1.95 |
NeuroMetrix | NURO | Sep 20, 2024 | 3.93 | +2.88 |
Neuronetics | STIM | Sep 20, 2024 | 0.93 | -1.87 |
NeuroOne | NMTC | Sep 20, 2024 | 0.92 | -1.35 |
Neuropace | NPCE | Sep 20, 2024 | 7.46 | +0.95 |
NeuroSense Therapeutics | NRSN | Sep 20, 2024 | 1.30 | -3.70 |
Nevro | NVRO | Sep 20, 2024 | 5.85 | 0.00 |
New America High Income Fund | HYB | Sep 20, 2024 | 8.25 | 0.00 |
New Concept Energy | GBR | Sep 20, 2024 | 1.15 | -2.55 |
New England Realty Associates LP Unit A | NEN | Sep 20, 2024 | 81.50 | 0.00 |
New Fortress Energy A | NFE | Sep 20, 2024 | 9.49 | -10.47 |
New Found Gold | NFGC | Sep 20, 2024 | 2.59 | +1.17 |
New Germany Fund | GF | Sep 20, 2024 | 8.60 | -1.41 |
New Gold | NGD | Sep 20, 2024 | 3.11 | +1.97 |
New Horizon Aircraft | HOVR | Sep 20, 2024 | 0.56 | -0.04 |
New Mountain Finance Corp | NMFC | Sep 20, 2024 | 11.95 | -0.83 |
New Oriental Education & Technology Group ADR | EDU | Sep 20, 2024 | 62.75 | +0.71 |
New Pacific Metals | NEWP | Sep 20, 2024 | 1.39 | +1.46 |
New Providence Acquisition II A | NPAB | Sep 20, 2024 | 11.90 | 0.00 |
New Providence Acquisition II Unit | NPABU | Sep 20, 2024 | 12.30 | 0.00 |
New Residential Investment A Pref | RITM-A | Sep 20, 2024 | 25.43 | -0.63 |
New Residential Investment B Pref | RITM-B | Sep 20, 2024 | 25.29 | -0.20 |
New Residential Investment C Pref | RITM-C | Sep 20, 2024 | 24.03 | -0.08 |
New Residential Investment D Pref | RITM-D | Sep 20, 2024 | 24.25 | +0.04 |
New York City REIT | NYC | Sep 20, 2024 | 9.70 | +6.59 |
New York Community Bancorp | NYCB | Sep 20, 2024 | 11.44 | -4.59 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.